What is the current stock price of Syndax Pharmaceuticals, Inc.?

As of the latest update, Syndax Pharmaceuticals, Inc.'s stock is trading at $18.48 per share.

What's happening with Syndax Pharmaceuticals, Inc. stock today?

Today, Syndax Pharmaceuticals, Inc. stock is up by 0.00%, possibly due to recent market activity.

What is the market sentiment around Syndax Pharmaceuticals, Inc. stock?

Current sentiment around Syndax Pharmaceuticals, Inc. stock is neutral, based on recent news, trading volume, and analyst opinions.

Is Syndax Pharmaceuticals, Inc.'s stock price growing?

Over the past month, Syndax Pharmaceuticals, Inc.'s stock price has decreased by 10.07%.

How can I buy Syndax Pharmaceuticals, Inc. stock?

You can buy Syndax Pharmaceuticals, Inc. stock through any brokerage platform, such as Robinhood, Fidelity, or E*TRADE, by searching for the ticker symbol SNDX.

Who are the major shareholders of Syndax Pharmaceuticals, Inc. stock?

Major shareholders of Syndax Pharmaceuticals, Inc. include institutions such as BlackRock, Inc., Kynam Capital Management LP, The Vanguard Group, Inc., according to the latest filings.

SNDX

Syndax Pharmaceuticals Inc

$18.48

0.00%

Trade Ideas Performance

Latest Closed Trade Idea

$18.48

0.00%

We are loading your data. Please wait a moment.

Sentiment

News

Social

About

Events of Syndax Pharmaceuticals Inc (SNDX)

Over the past six months, Syndax Pharmaceuticals, Inc.'s stock price has been impacted by several events. In October 2025, the FDA approved Revuforj for relapsed or refractory AML with a susceptible NPM1 mutation, boosting adoption and sales. In November 2025, the company reported Q3 earnings with an EPS of -$0.700 USD. In December 2025, Revuforj was named "Best New Drug at the Scrip Awards 2025." In January 2026, Syndax and World Orphan Drug Alliance launched an accessibility program for Revuforj outside the U.S. In February 2026, the company reported Q4 and full-year 2025 financial results with an EPS of -$0.780 USD and a 38% increase in Revuforj net revenue. In April 2026, the company reported Q1 2026 financial results with an EPS of -$0.480 USD, beating estimates, and reported over $100 million in combined sales of Revuforj and Niktimvo. In May 2026, Stifel raised its price target on Syndax shares to $46, while Jefferies lowered its price target to $37.

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

What Is Online Stock Trading and How Does the Market Work?

Online stock trading allows you to buy and sell shares of companies using digital platforms — all from your computer or phone. When you purchase a stock, you’re buying a small piece of that company. If the company performs well, its stock price usually goes up, and your investment gains value. If it struggles, the stock price may fall. All of this happens on stock exchanges, like the New York Stock Exchange or Nasdaq. These are marketplaces where investors and traders come together electronically. Prices change constantly based on supply and demand — the more people want a stock, the higher the price. If more people are selling, the price usually drops. Today, tools like Edge Hound, a generative AI trading assistant, make it easier for beginners to understand market trends and stay informed. What once required hours of manual research can now be streamlined using AI-powered insights.

Make every trade make sense.

Get started for FREE

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community